Search En menu ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 130,000,000
    Countries
    Sector(s)
    Poland : € 130,000,000
    Services : € 130,000,000
    Signature date(s)
    18/12/2018 : € 130,000,000

    Summary sheet

    Release date
    30 May 2018
    Status
    Reference
    Signed | 18/12/2018
    20170342
    Project name
    Promoter - financial intermediary
    ADVANCED MEDICAL RESEARCH POLAND II
    REPUBLIC OF POLAND
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 130 million
    EUR 325 million
    Location
    Sector(s)
    • Services - Professional, scientific and technical activities
    Description
    Objectives

    The project will support the medical research carried out in the public medical universities and medical scientific institutes in Poland from 2018 to 2020.

    The purpose of the project is to enhance the quality and efficiency of scientific work and to augment academic research activities undertaken at medical universities and medical research institutes. The project is fully consistent with the Bank's Knowledge Economy objectives and Horizon 2020 targets. About 70% of the investments will take place in the convergence regions.

    Environmental aspects
    Procurement

    The project concerns investments in universities and public research facilities, which are not specifically mentioned in the Directive 2014/52/EU on Environmental Impact Assessment, though the project may be covered by Annex II of the Directive in relation to urban development. Full environmental details will be assessed during the appraisal, including the potential impacts of some of the capital investments concerned.

    The Bank will require the promoter to ensure that contracts for the implementation of the project have been/shall be tendered in accordance with the relevant applicable EU procurement legislation (Directives 2004/18/EC and/or 2004/17/EC as well as Directives 89/665/EEC and 92/13/EEC) as interpreted by the Court of Justice of the EU, with publication of tender notices in the Official Journal of the EU, as and where required.

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - ADVANCED MEDICAL RESEARCH POLAND II
    Publication Date
    14 Sep 2018
    Document language
    Main Topic
    Lending
    Document Number
    83814481
    Document Focus
    Environmental Information
    Project Number
    20170342
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now
    Environmental and Social Completion Sheet (ESCS) - ADVANCED MEDICAL RESEARCH POLAND II
    Publication Date
    25 Dec 2021
    Document language
    Main Topic
    Lending
    Document Number
    140543288
    Document Focus
    Environmental Information
    Project Number
    20170342
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications